GL1X · GenesisL1 explorer

MolNFT v1 · #132633 · protein

Pandda analysis group deposition -- crystal structure of human cleavage factor im in complex with EN08775-43

5R4U · Cleavage and polyadenylation specificity factor subunit 5: “Pandda analysis group deposition -- crystal structure of human cleavage factor im in complex with EN08775-43”. X-ray diffraction, 2 ligands (RWM, ZN), 3 pockets (best…

PDB
5R4U
Type
protein
Length
394 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cleavage and polyadenylation specificity factor subunit 5
UniProt
O43809
Ligands
RWM, ZN
Pockets
3 · best druggability 0.77

Structure

x-ray diffraction · 1 distinct chain · 24% helix, 38% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BCleavage and polyadenylation specificity factor subunit 5protein19724% helix, 38% strandO43809

Ligands and binding sites

  • RWM · (5S)-5-methyl-5-[(3-phenyl-1,2-oxazol-5-yl)methyl]pyrrolidine-2,4-dione · ligand · chains A
  • ZN · Zinc ion · metal · 6 copies · chains A, B
  • ACT · Acetate ion · additive · 3 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19490.770.7976RWM, ZN
24990.660.7839empty
3520.370.8020empty

Interfaces

1 interface between chains.

  • A–B · 221 Ų buried · 0 hydrogen bonds · protein-protein

Compared structures

  • 5R4U · PanDDA analysis group deposition -- Crystal Structure of HUMAN CLEAVAGE FACTOR IM in… · the same entry in another collection · chain A against A, TM-score 1.00
  • O43809 · AlphaFold monomer V2.0 prediction for cleavage and polyadenylation specificity factor… · a predicted model of the same protein · chain B against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.